# Outcomes of Transrenal Artery Perfusion Versus Transrenal Vein Perfusion Using LifePort for Deceased Donor Kidney Transplantation

> **NCT04569682** · NA · COMPLETED · sponsor: **West China Hospital** · enrollment: 108 (actual)

## Conditions studied

- Kidney Transplantation
- Organ Preservation

## Interventions

- **DEVICE:** LifePort transrenal artery perfusion
- **DEVICE:** LifePort transrenal vein perfusion

## Key facts

- **NCT ID:** NCT04569682
- **Lead sponsor:** West China Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-01
- **Primary completion:** 2021-10-30
- **Final completion:** 2022-12-30
- **Target enrollment:** 108 (ACTUAL)
- **Last updated:** 2023-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04569682

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04569682, "Outcomes of Transrenal Artery Perfusion Versus Transrenal Vein Perfusion Using LifePort for Deceased Donor Kidney Transplantation". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04569682. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*